A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer
Public ClinicalTrials.gov record NCT01379534. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Open-label, Single-arm, Non-randomized, Multi-center Study to Evaluate the Efficacy of Oral TKI258 as Second-line Therapy in Patients With Either FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a prospective, multi-center, open-label, single-arm, non-randomized, Phase II study to evaluate the efficacy and safety of TKI258 as second-line therapy in patients with either FGFR2 mutated or wild-type advanced and/or metastatic endometrial cancer.
Study identification
- NCT ID
- NCT01379534
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 53 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2011 (Type not available)
- Primary completion
- Mar 2014 (Actual)
- Completion
- Mar 2014 (Actual)
- Last update posted
- May 20, 2015
2011 – 2014
United States locations
- U.S. sites
- 21
- U.S. states
- 13
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of South Alabama / Mitchell Cancer Institute Univ South Alabama | Mobile | Alabama | 36688 | — |
| St. Jude Heritage Medical Group St Jude | Fullerton | California | 92835 | — |
| USC/Kenneth Norris Comprehensive Cancer Center USC 2 | Los Angeles | California | 90033 | — |
| Cedars Sinai Medical Center TKI258A2211 (SC) | Los Angeles | California | 90048 | — |
| University of California at Los Angeles UCLA 3 | Los Angeles | California | 90095 | — |
| Rocky Mountain Cancer Centers Dept. of Rocky Mountain Cancer | Greenwood Village | Colorado | — | — |
| Florida Hospital Cancer Institute FL Hosp | Orlando | Florida | 32804 | — |
| Indiana University Health Goshen Center for Cancer IU Simon Cancer | Indianapolis | Indiana | 46202 | — |
| University of Iowa Hospitals & Clinics SC | Iowa City | Iowa | 52242 | — |
| Dana Farber Cancer Institute SC | Boston | Massachusetts | 02115 | — |
| Southeast Nebraska Oncology Cancer Center | Lincoln | Nebraska | 68510 | — |
| Hope A Woman's Cancer Center | Asheville | North Carolina | 28806 | — |
| Duke University Medical Center Duke3 | Durham | North Carolina | 27710 | — |
| Community Oncology Research Network | Chattanooga | Tennessee | 37403 | — |
| The West Clinic SC | Memphis | Tennessee | 38120 | — |
| Texas Oncology, P.A. Austin | Bedford | Texas | 76022 | — |
| Texas Oncology, P.A. Tex Onc (3) | Bedford | Texas | 76022 | — |
| Texas Oncology, P.A. SC | Fort Worth | Texas | 76104 | — |
| South Texas Oncology and Hematology, PA South Tex Onc | San Antonio | Texas | 78258 | — |
| Virginia Oncology Associates VOA - Lake Wright | *see Various Departments* | Virginia | — | — |
| Cancer Care Northwest SC | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 24 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01379534, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 20, 2015 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01379534 live on ClinicalTrials.gov.